Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Dades bibliogràfiques
Autors principals:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Format:	Conference item
Idioma:	English
Publicat:	Cell Press 2021

Ítems similars

Development of protocols for mouse GLP-toxicology studies
per: Sinadinos, A, et al.
Publicat: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
per: Sinadinos, A, et al.
Publicat: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
per: Sergijenko, A, et al.
Publicat: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
per: Sergijenko, A, et al.
Publicat: (2020)

Gene therapy for respiratory diseases; progress and a changing context
per: Alton, EWFW, et al.
Publicat: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
per: Balázs Bender, et al.
Publicat: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
per: Tan, T, et al.
Publicat: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
per: Helena Lund-Palau, et al.
Publicat: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
per: Tan, TK, et al.
Publicat: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
per: Gelinas, J, et al.
Publicat: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
per: Gélinas, J, et al.
Publicat: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
per: Conway, CC, et al.
Publicat: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
per: Sinadinos, A, et al.
Publicat: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
per: Ashworth, R, et al.
Publicat: (2018)

Lentiviral Vector Bioprocessing
per: Christopher Perry, et al.
Publicat: (2021-02-01)

Production of lentiviral vectors
per: Otto-Wilhelm Merten, et al.
Publicat: (2016-01-01)

Advances of Lentiviral Vectors
per: Fanrong MENG, et al.
Publicat: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
per: Munday, R, et al.
Publicat: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
per: Munday, R, et al.
Publicat: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
per: Antepowicz, A, et al.
Publicat: (2021)

The very stable lentiviral vector
per: Gwendolyn K. Binder, et al.
Publicat: (2024-03-01)

Special Issue “Lentiviral Vectors”
per: Yasuhiro Takeuchi
Publicat: (2022-07-01)

The Inside Out of Lentiviral Vectors
per: Stéphanie Durand, et al.
Publicat: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
per: Agata Antepowicz, et al.
Publicat: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
per: Griesenbach, U, et al.
Publicat: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
per: Hyde, S, et al.
Publicat: (2016)

Lentiviral Vectors for Ocular Gene Therapy
per: Yvan Arsenijevic, et al.
Publicat: (2022-07-01)

Comparison of lentiviral vector titration methods
per: Debyser Zeger, et al.
Publicat: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
per: Logan Y. Brown, et al.
Publicat: (2020-12-01)

Rev-dependent lentiviral expression vector
per: Beddall Margaret H, et al.
Publicat: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
per: Yáñez-Muñoz, R, et al.
Publicat: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
per: Inès Dufait, et al.
Publicat: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
per: Massimo Conese, et al.
Publicat: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
per: Patrick L Sinn, et al.
Publicat: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
per: Munday, RJ, et al.
Publicat: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
per: Munday, RJ, et al.
Publicat: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
per: Griesenbach, D, et al.
Publicat: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
per: Alton, E, et al.
Publicat: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
per: Alton, E, et al.
Publicat: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
per: Munday, RJ, et al.
Publicat: (2022)